Výsledky vyhledávání - Vaibhav Sahai

Upřesnit hledání
  1. 1
    Statistical medium optimization and production of a hyperthermostable lipase from Burkholderia cepacia in a bioreactor

    Statistical medium optimization and production of a hyperthermostable lipase from Burkholderia cepacia in a bioreactor Autor Pooja Rathi, Vineet Kumar Goswami, Vaibhav Sahai, Rani Gupta

    Vydáno 2002
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma

    Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma Autor Anne F. Buckley, Lawrence J. Burgart, Vaibhav Sahai, Sanjay Kakar

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Opportunities and Challenges for Pancreatic Circulating Tumor Cells

    Opportunities and Challenges for Pancreatic Circulating Tumor Cells Autor Sunitha Nagrath, Rhonda M. Jack, Vaibhav Sahai, Diane M. Simeone

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression

    Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression Autor Surabhi Dangi‐Garimella, Vaibhav Sahai, Kazumi Ebine, Krishan Kumar, Hidayatullah G. Munshi

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma

    Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma Autor Sanjay Kakar, Guoren Deng, Thomas C. Smyrk, Lisa Cun, Vaibhav Sahai, Young S. Kim

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Targeting BET bromodomain proteins in solid tumors

    Targeting BET bromodomain proteins in solid tumors Autor Vaibhav Sahai, Amanda J. Redig, Katharine A. Collier, Frank Eckerdt, Hidayatullah G. Munshi

    Vydáno 2016
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study

    Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Revi... Autor Jonathan Strosberg, Al B. Benson, Lynn Huynh, Mei Sheng Duh, Jamie Goldman, Vaibhav Sahai, Alfred Rademaker, Matthew H. Kulke

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen

    BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen Autor Vaibhav Sahai, Krishan Kumar, Lawrence M. Knab, Christina R. Chow, Sania S. Raza, David J. Bentrem, Kazumi Ebine, Hidayatullah G. Munshi

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis

    Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis Autor Mario A. Shields, Kazumi Ebine, Vaibhav Sahai, Krishan Kumar, Kulsumjehan Siddiqui, Rosa F. Hwang, Paul J. Grippo, Hidayatullah G. Munshi

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01

    A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01 Autor Vaibhav Sahai, Kent A. Griffith, Muhammad S. Beg, Walid L. Shaib, Devalingam Mahalingam, David B. Zhen, Dustin A. Deming, Mark M. Zalupski

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    P-286 Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 study

    P-286 Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-l... Autor Vincent, Picozzi, Caio, Rocha Lima, Vaibhav, Sahai, Diane, Simeone, Allyson, Ocean, Philip, Philip, Wasif, Saif, Aparna, Kalyan, Michael, Ondovik, Jack, Shiansong Li, Victoria, Manax

    Vydáno 2016
    Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma

    Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma Autor Vaibhav Sahai, Paul J. Catalano, Mark M. Zalupski, Sam Joseph Lubner, Mark R. Menge, Halla Nimeiri, Hidayatullah G. Munshi, Al B. Benson, Peter J. O’Dwyer

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging

    Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging Autor Marina Baretti, Soumya Shekhar, Vaibhav Sahai, Daniel Shu, Kathryn L. Howe, Valerie Gunchick, Naziheh Assarzadegan, Emma Kartalia, Qingfeng Zhu, Elsa Hallab, Archit Sheth-Shah, Aya Kondo, Nilofer S. Azad, Mark Yarchoan

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

    Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma Autor Edward Kim, Vaibhav Sahai, Ethan V. Abel, Kent A. Griffith, Joel K. Greenson, Naoko Takebe, Gazala Khan, John Blau, Ronald A. Craig, Ulysses J. Balis, Mark M. Zalupski, Diane M. Simeone

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer

    ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer Autor Yiannis Drosos, David Escobar, Ming-Yi Chiang, Kathryn Roys, Virginia Valentine, Marc Valentine, Jerold E. Rehg, Vaibhav Sahai, Lesa Begley, Jianming Ye, Leena Paul, Peter J. McKinnon, Beatriz Sosa‐Pineda

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer

    Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer Autor Kyle C. Cuneo, Meredith A. Morgan, Vaibhav Sahai, Matthew J. Schipper, Leslie A. Parsels, Joshua D. Parsels, Theresa P. Devasia, Mahmoud Al-Hawaray, Clifford S. Cho, Hari Nathan, Jonathan Maybaum, Mark M. Zalupski, Theodore S. Lawrence

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

    Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer Autor Richard D. Kim, Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai, George P. Keogh, Edward Kim, Ari David Baron, Abby B. Siegel, Afsaneh Barzi, Katherine A. Guthrie, Milind Javle, Howard S. Höchster

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer

    GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer Autor Meghna Waghray, Malica Yalamanchili, Michele Dziubinski, Mina Zeinali, Marguerite Erkkinen, Huibin Yang, Kara A. Schradle, Sumithra Urs, Marina Pasca di Magliano, Theodore H. Welling, Phillip L. Palmbos, Ethan V. Abel, Vaibhav Sahai, Sunitha Nagrath, Lidong Wang, Diane M. Simeone

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

    Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial Autor Michael J. Pishvaian, Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa, Andrew Hendifar, Sam Mikhail, Vincent Chung, Vaibhav Sahai, Davendra Sohal, Sara Bellakbira, Dzung Thach, Lola Rahib, Subha Madhavan, Lynn M. Matrisian, Emanuel F. Petricoin

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

    Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04) Autor Arathi Mohan, Kent A. Griffith, Fulei Wuchu, David B. Zhen, Chandan Kumar‐Sinha, Oxana Crysler, David Hsiehchen, Thomas Enzler, Dominique Dippman, Valerie Gunchick, Abhinav Achreja, Olamide Animasahun, Srinadh Choppara, Minal Nenwani, Arul M. Chinnaiyan, Deepak Nagrath, Mark M. Zalupski, Vaibhav Sahai

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: